Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07803744 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

Name: A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity — clinical trial record (NCT07803744)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-09

View on ClinicalTrials.gov ↗

The main purpose of this study is to learn more how tirzepatide affects stomach emptying in participants with Type 1 Diabetes Mellitus (T1DM) and overweight or obesity. Participation in this study will last about 8 weeks, including screening and follow-up.

Trial Details

NCT Number	NCT07803744
Lead Sponsor	Eli Lilly and Company
Conditions	Diabetes Mellitus, Type 1, Overweight, Obesity
Enrollment	18 participants
Start Date	2026-09
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-04